查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1801174

2025 年至 2033 年痤疮药物市场规模、份额、趋势及预测（按痤疮类型、药物类别、药物类型、给药途径和地区划分）

Acne Drugs Market Size, Share, Trends and Forecast by Acne Type, Drug Class, Drug Type, Route of Administration, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球痤疮药物市场规模达72亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到112亿美元，2025-2033年期间的复合年增长率（CAGR）为4.9%。市场成长的主要驱动力包括：成人和青少年痤疮盛行率的上升、人们对护肤的认知和重视程度的提升、创新疗法药物研发的持续进步，以及社交媒体影响力的不断增强。

全球痤疮药物市场趋势：

痤疮盛行率不断上升

全球成年人和青少年中痤疮盛行率的不断上升是推动痤疮药物市场统计数据成长的主要原因。此外，青春期荷尔蒙变化的加剧、个人压力水平的高涨以及不良饮食和不充分的皮肤护理等多种生活方式因素预计将推动市场成长。除此之外，各大製药公司为创新、方便和可靠的痤疮药物所做的广泛研发工作也对市场扩张产生了正面影响。例如，ClickPharmacy 发布的资料显示，34% 的英国成年人在一生中的某个阶段都曾患过痤疮。同一消息来源提到，目前男性患有痤疮的比例为 6.1%，而女性的比例为 2.5%。此外，《萨赫勒医学杂誌》发表的文章提到，南尼日利亚寻常性痤疮的盛行率为 37.3%，女性盛行率（37.6%）高于男性（36.7%）。有鑑于此，许多关键参与者正致力于推出合适的痤疮治疗方案，以惠及广大痤疮患者。例如，2023年6月，太阳製药工业有限公司（Sun Pharmaceutical Industries Ltd.）的WINLEVI乳膏获得了加拿大卫生部（该国卫生监管机构）的批准，用于治疗痤疮和痤疮疤痕。

护肤意识和重视程度不断提高

人们对护肤和个人形象的日益重视和关注，促进了痤疮药物市场的成长。此外，尤其是在发展中经济体，个人在护肤产品和有助于打造洁净无瑕肌肤的疗法上的支出不断增长，也催化了全球市场的发展。此外，社群媒体和名人代言的影响力日益增强，以及对改善肤质疗法的需求不断增长，也对市场成长产生了正面的影响。例如，高德美公司推出了一项名为「做我自己」的全新数位行销活动，推广Aklief（三氟甲磺酸）乳膏的局部痤疮治疗。该公司向患者普及了Aklief的知识，这是20多年来首个获准用于治疗寻常性痤疮的新型类维生素A分子。此外，Stryke Club还推出了Knockout Adapalene凝胶，用于治疗类维生素A痤疮，可预防粉刺、黑头、白头和毛孔阻塞。此外，2023年9月，Marksans Pharma完成对印度Teva Pharmaceuticals的收购，以继续为客户和患者不间断地供应Teva的重要药品。

药物研发的进步

药物研发领域的不断进步，为痤疮治疗创造了创新且更有效率的配方，这对市场成长产生了积极的影响。此外，监管机构在研究和引进最新改良型痤疮药物方面不断增加的投资，也推动了市场扩张。此外，改进的药物传输系统的日益普及、新型活性成分的发现以及针对痤疮各个方面的联合疗法的广泛采用，进一步促进了痤疮药物市场的收入成长。例如，高德美公司在马萨诸塞州波士顿举行的美国皮肤病学会 (AAD) 年会上宣布在美国推出其 0.1%/3% 的「Twyneo」乳膏。 TWYNEO 乳膏是第一个也是唯一一个经证实可快速治疗中度至重度脸部痤疮的 0.1% 维他命A酸和 3% 过氧化苯甲酰 (BPO) 二合一组合产品。此外，2023年5月，博士伦医疗公司（Bausch Health Companies Inc.）宣布，美国食品药物管理局（FDA）根据处方药使用者付费法案（PDUFA）接受了试验性IDP-126（克林霉素1.2%/阿达帕林0.15%/过氧化苯甲酰3.1%）凝胶的新药申请（NDA）凝胶的新药申请（NDA）。

全球痤疮药物市场细分

根据痤疮类型分手：

  • 粉刺性
  • 发炎
  • 囊性
  • 手术后/伤口

在粉刺性痤疮领域，非发炎性痤疮的高发病率、非处方药日益普及以及人们对洁净无瑕肌肤的渴望，是市场成长的主要驱动力。此外，对强效抗发炎药物日益增长的需求，以及为开发有效痤疮治疗方案而进行的持续研究，也催化了发炎性痤疮市场的发展。此外，处方药需求的不断增长、先进疗法的日益普及、术后护肤要求的不断提高以及美容手术的兴起，都在推动囊性痤疮和术后/伤口痤疮药物市场的扩张。

按毒品类别分类：

  • 类视黄酸
  • 抗生素
  • 荷尔蒙药物
  • 联合用药
  • 其他的

类视黄醇占据市场主导地位

人们对使用类维生素A治疗痤疮的认识不断提高，这在很大程度上推动了该领域的市场成长。此外，由于类维生素A能够调节皮肤细胞更新、预防粉刺（黑头和白头）形成以及减少炎症，医护人员和个人对有效痤疮治疗产品的需求也十分广泛，这也进一步促进了市场的成长。

依毒品类型分类：

  • 非处方药
  • 处方药

非处方药 (OTC) 的便捷获取以及个人护理方案日益增长的兴趣，推动了痤疮药物市场在这一领域的成长。此外，消费者对常见皮肤问题的速效疗法的需求日益增长，这些疗法在超市、药局和线上商店随处可见，也对全球痤疮药物的需求产生了积极影响。例如，太阳製药 (Sun Pharma) 与 TLC 电视网的皮肤科医生 Sandra Lee 博士合作，透过名为「啊哈！痤疮激素」的活动，重点关注激素在皮肤痤疮根本病因中的作用。该活动邀请了不同年龄、性别和种族的人群，指导美国民众遵循可能涉及 OTC 产品的有效皮肤护理方案。

依给药途径分类：

  • 外用
  • 口服
  • 注射剂

外用药物在市场上占有最大份额

局部治疗的便利性对痤疮药物市场前景至关重要，因为这些产品易于直接涂抹于患处，使其成为许多寻求局部痤疮治疗人士的首选。此外，製药业持续的研发工作，旨在推出副作用更少、疗效更佳的创新配方，也催化了该领域的市场成长。例如，美国食品药物管理局 (FDA) 批准了 Opzelura（芦可替尼），这是一款用于治疗 12 岁及以上无法使用其他疗法或无法从其他疗法中获得足够症状缓解的轻度至中度异位性皮肤炎患者的乳膏。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美占据明显优势，占据痤疮药物市场最大份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告显示，北美占据了最大的市场份额。

北美是痤疮药物市场最大的细分市场，这得益于其先进的医疗基础设施和不断增长的个人消费能力。此外，青少年和成年人痤疮的高发病率、先进医疗技术的发展以及医疗专业人员和皮肤科医生的便利就诊，也催化了该地区市场的成长。此外，个人对保持外表和美丽的日益增长的追求也对市场成长产生了积极的影响。例如，在加拿大，博士伦医疗的子公司Ortho Dermatologics公布了其IDP-126第二阶段III期临床试验的积极资料。 IDP-126是一种由三种化合物组成的复合凝胶，在193名寻常性痤疮患者中进行了测试。此临床试验表明，在第12週，两种痤疮患者的发炎和非发炎性病变均有所减少。 IDP-126结合了阿达帕林、视黄醇和抗菌过氧化苯甲酰。

竞争格局：

全球痤疮药物市场的竞争格局以众多製药和医疗保健公司为特色，这些公司致力于提供创新有效的痤疮治疗解决方案。应用户要求，本文未提及具体参与者，但值得注意的是，市场透过研发、策略合作和产品多样化来促进竞争。该领域的公司不断投资研发，以研发针对各种类型痤疮（从轻度到重度）的新药物和疗法。与皮肤科医生和护肤专家的合作有助于推广其产品，提升信誉并扩大市场影响力。此外，包括数位行销和社交媒体在内的行销策略在推广产品和教育消费者有效痤疮管理方面发挥关键作用。竞争格局强调了品质、安全和创新在满足寻求痤疮治疗的个人多样化需求方面的重要性，最终使消费者受益于更广泛的选择和更完善的解决方案。

市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。痤疮药物行业的一些主要市场参与者包括：

  • 艾尔建公司
  • 博士伦保健公司
  • 拜耳股份公司
  • Cipher製药公司
  • 高德美控股公司
  • 强生公司
  • 辉瑞公司
  • 利洁时集团
  • Skinvisible製药公司
  • 太阳製药工业有限公司
  • 梯瓦製药工业股份有限公司

本报告回答的关键问题

  • 全球痤疮药物市场有多大
  • 2025-2033年全球痤疮药物市场的预期成长率是多少
  • 推动全球痤疮药物市场的关键因素有哪些
  • COVID-19 对全球痤疮药物市场有何影响
  • 根据药物类别，全球痤疮药物市场如何划分
  • 根据给药途径，全球痤疮药物市场如何分布
  • 全球痤疮药物市场的主要区域有哪些
  • 全球痤疮药物市场的主要参与者/公司是谁

本报告回答的关键问题

  • 全球痤疮药物市场有多大？ 2025-2033年全球痤疮药物市场的预期成长率是多少？
  • 推动全球痤疮药物市场发展的关键因素有哪些？
  • COVID-19 对全球痤疮药物市场有何影响？
  • 根据药物类别，全球痤疮药物市场是如何分布的？
  • 根据给药途径，全球痤疮药物市场如何分布？
  • 全球痤疮药物市场的主要区域有哪些？
  • 全球痤疮药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球痤疮药物市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：按痤疮类型

  • 粉刺性
  • 发炎
  • 囊性
  • 手术后/伤口

第七章：市场区隔：依药品类别

  • 类视黄酸
  • 抗生素
  • 荷尔蒙药物
  • 联合用药
  • 其他的

第八章：市场区隔：依药物类型

  • 非处方药
  • 处方药

第九章：市场细分：依行政途径

  • 外用
  • 口服
  • 注射剂

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Allergan Plc
    • Bausch Health Companies Inc.
    • Bayer Aktiengesellschaft
    • Cipher Pharmaceuticals Inc.
    • Galderma Holding SA
    • Johnson & Johnson
    • Pfizer Inc.
    • Reckitt Benckiser Group Plc
    • Skinvisible Pharmaceuticals Inc.
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112025A2359

The global acne drugs market size reached USD 7.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.2 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The market is primarily driven by the rising prevalence of acne among adults and adolescents, the increasing awareness and emphasis on skincare, the ongoing advancements in pharmaceutical R&D for innovative treatments, and the emerging social media influence.

Global Acne Drugs Market Trends:

Increasing Prevalence of Acne

The increasing prevalence of acne among adults and adolescents across the globe is primarily driving the acne drug market statistics. Moreover, the rising hormonal changes during puberty, high stress levels of individuals, and several lifestyle factors, including poor diet and inadequate skincare routines are anticipated to propel the market growth forward. Besides this, the extensive research and development efforts by the major pharmaceutical companies for creative innovative, accessible, and reliable acne medications are also positively influencing the market expansion. For instance, the data published by ClickPharmacy reported that 34% of United Kingdom adults have suffered from acne at some point in their lives. The same source mentioned that 6.1% of men are currently suffering from acne when compared to 2.5% of women. Also, the article published by Sahel Medical Journal mentioned that the prevalence of acne vulgaris in South Nigeria was 37.3% with a higher prevalence in females (37.6%) than in males (36.7%). On account of this, numerous key players are focusing on the introduction of adequate acne treatment solutions to reach out to a large patient base suffering from acne. For example, in June 2023, Sun Pharmaceutical Industries Ltd., received approval from Health Canada, the country's health regulator, for its WINLEVI cream, used in treating acne and acne scars.

Growing Awareness and Emphasis on Skincare

The growing emphasis and awareness regarding skincare and personal appearance is augmenting the acne drugs market growth. Moreover, the inflating expenditures by individuals, especially in developing economies, on skincare products and treatments that aid in achieving clear and blemish-free skin are also catalyzing the global market. Besides this, the increasing influence of social media and celebrity endorsements and the escalating demand for therapies that enhance the appearance of the skin are also positively influencing the market growth. For example, Galderma launched a new digital campaign. "Me Being Me" for topical acne treatment with Aklief (trifarotene) Cream. The company educated patients about Aklief, which is the first new retinoid molecule to gain approval for acne vulgaris in more than 20 years. In addition to this, Stryke Club introduced retinoid acne treatment with its Knockout Adapalene Gel that prevents pimples, blackheads, whiteheads, and clogged pores. Moreover, in September 2023, Marksans Pharma completed the acquisition of Teva Pharmaceuticals in India to continue providing an uninterrupted supply of Teva's important medicines to customers and patients.

Advancements in Pharmaceutical Research and Development

The continuous advancements in pharmaceutical research and development for creating innovative and more efficient formulations for acne treatment are positively influencing the market growth. In addition to this, the inflating investments by regulatory authorities in the study and introduction of the latest and improved acne drugs are also propelling the market expansion. Moreover, the growing popularity of improved drug delivery systems, the discovery of novel active ingredients, and the widespread adoption of combination therapies that target various aspects of acne are further catalyzing the acne drug market revenue. For instance, Galderma announced the U.S. launch of its "Twyneo" Cream, 0.1%/3% at the American Academy of Dermatology (AAD) Annual Meeting in Boston, Massachusetts. TWYNEO Cream is the first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 combination proven to rapidly treat moderate to severe facial acne. Moreover, in May 2023, Bausch Health Companies Inc. announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for investigational IDP-126 (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%) Gel with a Prescription Drug User Fee Act (PDUFA).

Global Acne Drugs Market Segmentation

Breakup by Acne Type:

  • Comedonal
  • Inflammatory
  • Cystic
  • Postsurgical/Wound

In the comedonal segment, the high prevalence of non-inflammatory acne cases, increasing accessibility to over-the-counter remedies, and the desire for clear, blemish-free skin are primarily driving the market growth. Besides this, the escalating demand for potent anti-inflammatory agents and the ongoing research activities for the development of effective acne treatment solutions are catalyzing the market in the inflammatory segment. Moreover, the rising need for prescription-based medications, the growing popularity of advanced therapies, the elevating requirement for post-procedure skincare, and the emerging trend of cosmetic surgeries, are propelling the expansion of the acne drugs market in the cystic and postsurgical/wound segments.

Breakup by Drug Class:

  • Retinoids
  • Antibiotics
  • Hormonal Agents
  • Combination Drugs
  • Others

Retinoids dominate the market

The rising awareness towards the utilization of retinoids in acne treatment is majorly fueling the market growth in this segment. Besides this, the extensive product need among healthcare professionals and individuals for effective acne treatment, owing to their ability to regulate skin cell turnover, prevent the formation of comedones (blackheads and whiteheads), and reduce inflammation, is augmenting the market growth further.

Breakup by Drug Type:

  • OTC Drugs
  • Prescription Drugs

The easy accessibility of over-the-counter (OTC) drugs and the increasing individual interest in self-care solutions are bolstering the growth of the acne drug market in this segment. Besides this, the rising need for quick remedies, which are readily available in supermarkets, pharmacies, and online outlets, among consumers for common skin concerns is positively influencing the demand for acne drugs globally. For instance, Sun Pharma teamed up with dermatologist Dr. Sandra Lee on the TLC network to spotlight the role of hormones in the underlying cause of skin acne through a campaign called 'AH-ha! It's Acne Hormones'. The campaign featured a diverse group of people of age, gender, and ethnicity and guided the population of the U.S. to follow an effective skin care regimen that may involve OTC products.

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Topical holds the largest share in the market

The convenience of topical treatments plays a significant role in the acne drug market outlook, as these products are easy to apply directly to affected areas, making them a preferred choice for several individuals seeking localized acne management. Besides this, the ongoing research and development efforts in the pharmaceutical sector for the introduction of innovative formulations with fewer side effects and better outcomes are also catalyzing the market growth in this segment. For instance, the U.S. FDA approved Opzelura (ruxolitinib), a cream for treating mild to moderate atopic dermatitis in patients aged 12 years and older who are not able to use other treatments or fail to get enough symptom relief from other therapies.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest acne drugs market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America represented the largest segment for the acne drugs market, owing to its advanced healthcare infrastructure and the inflating expenditure capacities of individuals. Besides this, the high prevalence of acne among adolescents and adults, the development of state-of-the-art medical technology, and the easy accessibility to medical professionals and dermatologists are also catalyzing the growth of the market in this region. In addition to this, the rising individual inclination towards maintaining their appearance and beauty is positively influencing the market growth. For instance, in Canada, Bausch Health's subsidiary Ortho Dermatologics announced positive topline data from its second Phase III trial for IDP-126, a three-compound combination gel tested in 193 patients with acne vulgaris. This clinical trial showed reductions in both inflammatory and non-inflammatory lesions at week 12 in both problems. IDP-126 combines adapalene, retinol, and anti-microbial benzoyl peroxide.

Competitive Landscape:

The competitive landscape of the global acne drugs market is characterized by a diverse array of pharmaceutical and healthcare companies striving to offer innovative and effective solutions for acne treatment. While specific players are not mentioned here due to the user's request, it's important to note that the market fosters competition through research and development, strategic collaborations, and product diversification. Companies within this space are continually investing in R&D to formulate new medications and therapies that target various types of acne, ranging from mild to severe cases. Partnerships with dermatologists and skincare experts help in endorsing their products, adding credibility and market reach. Furthermore, marketing strategies, including digital marketing and social media, play a pivotal role in promoting their products and educating consumers about effective acne management. The competitive landscape emphasizes the importance of quality, safety, and innovation in addressing the diverse needs of individuals seeking acne treatments, ultimately benefiting consumers with a wider range of options and improved solutions.

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the major market players in the Acne Drugs industry include:

  • Allergan Plc
  • Bausch Health Companies Inc.
  • Bayer Aktiengesellschaft
  • Cipher Pharmaceuticals Inc.
  • Galderma Holding SA
  • Johnson & Johnson
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Skinvisible Pharmaceuticals Inc.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the global acne drugs market?
  • 2.What is the expected growth rate of the global acne drugs market during 2025-2033?
  • 3.What are the key factors driving the global acne drugs market?
  • 4.What has been the impact of COVID-19 on the global acne drugs market?
  • 5.What is the breakup of the global acne drugs market based on the drug class?
  • 6.What is the breakup of the global acne drugs market based on the route of administration?
  • 7.What are the key regions in the global acne drugs market?
  • 8.Who are the key players/companies in the global acne drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Acne Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Acne Type

  • 6.1 Comedonal
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Inflammatory
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cystic
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Postsurgical/Wound
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Retinoids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Antibiotics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hormonal Agents
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Combination Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Drug Type

  • 8.1 OTC Drugs
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Prescription Drugs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Topical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cipher Pharmaceuticals Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Galderma Holding SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Reckitt Benckiser Group Plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Skinvisible Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sun Pharmaceutical Industries Limited
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Teva Pharmaceutical Industries Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Acne Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Acne Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Acne Drugs Market: Breakup by Acne Type (in %), 2024
  • Figure 4: Global: Acne Drugs Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Acne Drugs Market: Breakup by Drug Type (in %), 2024
  • Figure 6: Global: Acne Drugs Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Acne Drugs Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Acne Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Acne Drugs (Comedonal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Acne Drugs (Comedonal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Acne Drugs (Inflammatory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Acne Drugs (Inflammatory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Acne Drugs (Cystic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Acne Drugs (Cystic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Acne Drugs (Postsurgical/Wound) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Acne Drugs (Postsurgical/Wound) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Acne Drugs (Retinoids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Acne Drugs (Retinoids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Acne Drugs (Antibiotics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Acne Drugs (Antibiotics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Acne Drugs (Hormonal Agents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Acne Drugs (Hormonal Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Acne Drugs (Combination Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Acne Drugs (Combination Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Acne Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Acne Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Acne Drugs (OTC Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Acne Drugs (OTC Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Acne Drugs (Prescription Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Acne Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Acne Drugs (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Acne Drugs (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Acne Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Acne Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Acne Drugs (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Acne Drugs (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia Pacific: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia Pacific: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Acne Drugs Industry: SWOT Analysis
  • Figure 86: Global: Acne Drugs Industry: Value Chain Analysis
  • Figure 87: Global: Acne Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Acne Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Acne Drugs Market Forecast: Breakup by Acne Type (in Million USD), 2025-2033
  • Table 3: Global: Acne Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 4: Global: Acne Drugs Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 5: Global: Acne Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 6: Global: Acne Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Acne Drugs Market Structure
  • Table 8: Global: Acne Drugs Market: Key Players